Lixisenatide
- CAS number
- 320367-13-3
- Application
- Lixisenatide is a recombinant DNA produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes.
- Molecular weight
- 4858 g/mol
- Molecular formula
- C215H347N61O65S
SOCOSUR OEL/OEB Risk Assessments are a quick and efficient way to obtain:
- Complete review of all relevant toxicological and medical databases as well as Material Safety Data Sheets and chemical books, in accordance with the regulations from National Institute for Occupational Safety and Health (NIOSH), Naumann and Safebridge
- A classification in four categories based on CLP Regulation and Naumann and Safebridge proposals
- A rational for NOAEL values selection
- Categorization for the specific work conditions
Benefits of such OEL/OEB Assessment
A 20 to 30 pages report signed by an European toxicological expert, optimized in case of Regulatory Body inspection, with all calculation details and all bibliographic references linked to these calculations, as well as all the development and results for the categorization of the product.